FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085739 [Registered on: 28/04/2025] Trial Registered Prospectively
Last Modified On: 26/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   patients undergoing lower limb orthopaedic surgeries will be participants divided into two groups and they will be given spinal anaesthesia with bupivacaine and nalbuphine in one group and bupivacaine and fentanyl in another group 
Scientific Title of Study   Nalbuphine versus Fentanyl as an Intrathecal Adjuvant to Hyperbaric Bupivacaine in Lower Limb Orthopaedic Surgeries 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sanskruti Purohit 
Designation  Junior Resident in Department of Anaesthesiology 
Affiliation  Veer Surendra Sai Institute of Medical Sciences and Research  
Address  Depertment of Anaesthesiology VIMSAR BURLA
BURLA SAMBALPUR
Sambalpur
ORISSA
768017
India 
Phone  8280264444  
Fax    
Email  doc.sp09@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Dulal Kishun Soren 
Designation  Professor and HOD, Department of Anaesthesiology 
Affiliation  Veer Surendra Sai Institute of Medical Sciences and Research  
Address  Apala Hostel VIMSAR BURLA
BURLA SAMBALPUR
Sambalpur
ORISSA
768017
India 
Phone  9437254980  
Fax    
Email  dulalsoren@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sanskruti Purohit 
Designation  Junior Resident in Department of Anaesthesiology 
Affiliation  Veer Surendra Sai Institute of Medical Sciences and Research  
Address  Department of Anaesthesiology VIMSAR BURLA
BURLA SAMBALPUR
Sambalpur
ORISSA
768017
India 
Phone  8280264444  
Fax    
Email  doc.sp09@gmail.com  
 
Source of Monetary or Material Support  
Veer Surendra Sai Institute of Medical Sciences and Research Burla, Sambalpur Odisha, India Pin-768017  
 
Primary Sponsor  
Name  Veer Surendra Sai Institute of Medical Sciences and Research 
Address  Burla Sambalpur Odisha India Pin-768017 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanskruti Purohit  Veer Surendra Sai institute of Medical Sciences and research   Burla Sambalpur
Sambalpur
ORISSA 
8280264444

doc.sp09@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Veer Surendra Sai Institutional Research and Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S723||Fracture of shaft of femur,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Spinal Anaesthesia  Nalbuphine versus Fentanyl as an Intrathecal Adjuvant to Hyperbaric Bupivacaine in Lower Limb Orthopaedic Surgeries 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged between 18–60 years
Belonging to ASA Physical Status I or II
Of either sex
Undergoing elective lower limb orthopedic surgery under spinal anesthesia 
 
ExclusionCriteria 
Details  Patients who did not give informed consent
Known hypersensitivity to any of the study drugs
Pregnancy
Coagulation disorders, spinal deformities, local infection at the puncture site, or contraindications to spinal anesthesia 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of effective postoperative analgesia provided by intrathecal Nalbuphine and Fentanyl when used as adjuvants to hyperbaric Bupivacaine in patients undergoing lower limb orthopedic surgeries.
 
24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare the onset time of sensory & motor blockade between the Nalbuphine & Fentanyl groups.
2. To assess the duration of sensory & motor blockade produced by each adjuvant.
3. To evaluate the hemodynamic stability (heart rate, blood pressure variations) intraoperatively & postoperatively in both groups.
4. To compare the incidence of adverse effects, such as nausea, vomiting, pruritus, respiratory depression, bradycardia, & hypotension. 
24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This trial nalbuphine versus fentanyl as an intrathecal adjuvant to hyperbaric bupivacaine in lower limb orthopaedic surgeries will be undertaken to compare the duration of anaesthesia and postoperative analgesia of both the drugs in terms of onset of sensory and motor block and duration of blocks and also compare the hemodynamic stability and incidence of adverse effects of both drugs. 
Close